The House Committee on Health is set to conduct a congressional inquiry into the decision of the Food and Drug Administration (FDA) to disallow the use of an anti-parasitic drug called Ivermectin for prevention and treatment of coronavirus disease (COVID-19) infections. The panel will tackle House Resolution No. 1684 filed by 1-PACMAN Party-list Rep. Enrico […]
![](https://www.ikot.ph/wp-content/uploads/2021/03/3.31.2021-8-min-1200x674.jpg)